Stock Fundamentals

Company Information

Company Name
Unity Biotechnology Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US91381U2006
CIK: 0001463361
CUSIP: 91381U101
Currency: USD
Full Time Employees: 16
Phone: 650 416 1192
Fiscal Year End: December
IPO Date: May 03, 2018
Description:

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. Its lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. The company also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, an a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Address:

285 East Grand Avenue, South San Francisco, CA, United States, 94080

Directors & Officers

Name Title Year Born
Dr. Anirvan Ghosh Ph.D. CEO & Director 1965
Dr. Nathaniel E. David A.B., Ph.D. Co-Founder & Independent Director 1968
Ms. Lynne Marie Sullivan CPA CFO & Head of Corporate Development 1966
Mr. Alexander Hieu Nguyen J.D. Chief Legal Officer & Head of Operations 1978
Dr. Jan M. van Deursen Ph.D. Founder NA
Dr. Przemyslaw Sapieha Ph.D. Chief Scientist NA
Ms. Alicia Tozier M.B.A. Chief Strategy Officer NA
Dr. Federico Grossi M.D., Ph.D. Chief Medical Officer 1974

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 27, 2025 Alexander Hieu Nguyen N/A Sale 1.95K $1.16 $2.27K
Feb 04, 2025 Alexander Hieu Nguyen N/A Sale 164.00 $2.23 $365.72
Feb 04, 2025 Anirvan Ghosh N/A Sale 642.00 $2.23 $1.43K
Feb 04, 2025 Lynne Marie Sullivan N/A Sale 153.00 $2.23 $341.19

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
ARCH VENTURE CORP 1.00M Mar 31, 2025 5.84% $0.51 0.00%
Vanguard Group Inc 673.09K Jun 30, 2025 3.91% $0.00 0.00%
Financial Harvest, LLC 205.27K Mar 31, 2025 1.19% $6.98 0.00%
Geode Capital Management, LLC 166.21K Mar 31, 2025 0.97% $0.00 4.27%
Renaissance Technologies Corp 94.21K Mar 31, 2025 0.55% $0.00 22.49%
BlackRock Inc 81.40K Mar 31, 2025 0.47% $0.00 0.00%
Susquehanna International Group, LLP 62.74K Mar 31, 2025 0.36% $0.00 235.67%
Founders Fund V Management, LLC 49.17K Jun 30, 2025 0.29% $1.36 0.00%
Morgan Stanley - Brokerage Accounts 43.36K Mar 31, 2025 0.25% $0.00 -45.83%
State Street Corp 37.82K Mar 31, 2025 0.22% $0.00 0.00%
Northern Trust Corp 35.45K Mar 31, 2025 0.21% $0.00 57.22%
SIMPLEX TRADING, LLC 30.91K Mar 31, 2025 0.18% $0.00 0.00%
Group One Trading, LP 28.63K Mar 31, 2025 0.17% $0.00 0.00%
Seacrest Wealth Management, LLC 27.80K Jun 30, 2025 0.16% $0.00 0.00%
Commonwealth Equity Services Inc 26.11K Mar 31, 2025 0.15% $0.00 7.76%
Bridgeway Capital Management, LLC 25.00K Jun 30, 2025 0.15% $0.00 -50.00%
UBS Group AG 24.30K Mar 31, 2025 0.14% $0.00 195.09%
Virtu Financial LLC 18.05K Mar 31, 2025 0.10% $0.00 0.00%
Advisor Group Holdings, Inc. 12.55K Mar 31, 2025 0.07% $0.00 -0.59%
Endowment Wealth Management, Inc. 12.48K Jun 30, 2025 0.07% $0.00 0.00%

Shares Statistics

Shares Outstanding: 17.21M
Shares Float: 15.88M
% Insiders: 190.30%
% Institutions: 1,719.00%
Short % Float: 3.39%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 84.53K 0.49% ▲ 0.00% Jun 30, 2025
2 Extended Equity Market Fund K 35.87K 0.21% ▼ 1.96% Jun 30, 2025
3 Fidelity Total Market Index 27.56K 0.16% ▲ 0.00% Jun 30, 2025
4 Bridgeway Ultra-Small Company Market 25.00K 0.15% ▼ 50.00% Jun 30, 2025
5 Fidelity Series Total Market Index 23.97K 0.14% ▲ 0.00% Jun 30, 2025
6 Northern Trust Extended Eq Market Idx 23.01K 0.13% ▲ 0.00% Jun 30, 2025
7 NT Ext Equity Mkt Idx Fd - L 23.01K 0.13% ▲ 0.00% Jun 30, 2025
8 Spartan Extended Market Index Pool F 19.34K 0.11% ▲ 0.00% Jun 30, 2025
9 NT Ext Equity Mkt Idx Fd - NL 11.49K 0.07% ▲ 0.00% Jun 30, 2025
10 Spartan Total Market Index Pool G 9.66K 0.06% ▲ 0.00% Jun 30, 2025

Valuation Metrics

Enterprise Value: $3.17M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $3.44M
EBITDA: $-26.94M
Book Value: $-0.01
Earnings/Share: $-1.63
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.89%
ROE (TTM): -231.27%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 2.62x 0.00x 0.83x N/A 0.00x
2023-12-31 5.94x 0.12x 0.57x -18.22x -0.09x
2022-12-31 4.92x 0.35x 0.46x -16.18x -0.61x
2021-12-31 5.45x 0.43x 0.52x -17.84x -0.47x
2020-12-31 6.97x 0.35x 0.47x -72.70x -0.33x
2019-12-31 7.52x 0.00x 0.20x N/A 0.00x
2018-12-31 10.43x 0.00x 0.11x -23.99x 0.00x
2017-12-31 11.25x 0.00x 0.11x N/A 0.00x
2016-12-31 25.31x 0.00x 1.43x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about UBX.US!